NeuroStar® in the News

To learn more about how physicians throughout the country are successfully treating depression with NeuroStar TMS Therapy®, see the recent media coverage and press releases below.


Recent press coverage about NeuroStar TMS Therapy
2016
Jun
01
PM360 – NeuroStar Advocate Martha Rhodes Among Winners Of Second Annual Elite Awards
May
25
PMS360 – ELITE Patient Advocate Martha Rhodes
Mar
01
The Daily Show – TMS Therapy feature
2015
Nov
15
Lowell Sun News – For those with depression, magnetic brain stimulation offers hope

See archived articles about NeuroStar TMS Therapy


Recent press releases about NeuroStar TMS Therapy
2016
May
17
NeuroStar TMS Therapy®, a Non-Drug Treatment, Shows Promise as Monotherapy in Treating Women with Postpartum Depression
Mar
24
Depression Patients Who Are Successfully Treated With NeuroStar TMS Therapy May Not Need Antidepressant Medications
2015
Nov
02
Neuronetics Announces Launch of First Ever Randomized, Controlled Clinical Trial to Evaluate Non-Drug NeuroStar TMS Therapy® in Adolescent Patients with Major Depressive Disorder
Sep
01
Neuronetics Named PM360 Trailblazer Finalist for Medical Device Company of the Year
Apr
27
Neuronetics Closes $34 Million in Series F Financing with GE Ventures and Current Investors
Feb
23
Australians to Gain Access to Breakthrough Treatment for Depression

See archived press releases about NeuroStar TMS Therapy